TransMedics Group, Inc.
TMDX · Healthcare · $2.9B
Pre-market $83.88+0.52%
Price
$68.86
$84.07
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$176M-7.4%
6/'26 vs prev quarter
Company Health
Market Cap$2.9B
Operating Margin+12.2%
Cash on Hand$473M16.4% of market cap
Free Cash Flow$79M2.7% of market cap
Among 114 Medical - Devices peers
LowMedianHigh
PSR4.3xmedian 2.3xPER19.0xmedian 24.5xPBR5.6xmedian 2.5xROE+29.3%median -26.3%TransMedics Group Inc (TMDX) Shares Surge 3.2% -- What GF Score of 69 Tells InvestorsSep 3
Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?Sep 3
Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?Sep 3
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDXSep 2
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDXAug 31
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDXAug 29
